stethoscope_gavel_book_law_health_medicine_1200x630

Nebraska Attorney General: Physicians Should be Allowed to Use Off-Label Ivermectin & Hydroxychloroquine for COVID-19

In what some might consider a bombshell breakthrough, the Attorney General of the State of Nebraska provided a legal opinion to the state’s Health and Human Services Department head.

October 15, 2021 | Source: Trial Site News | by

In what some might consider a bombshell breakthrough, the Attorney General of the State of Nebraska provided a legal opinion to the state’s Health and Human Services Department head. This just-released formal legal opinion suggests that the off-label use of ivermectin and hydroxychloroquine for the prevention or treatment of COVID-19 is acceptable. The Attorney General’s conclusions: “Allowing physicians to consider these early treatments will free them to evaluate additional tools that could save lives, keep patients out of the hospital, and provide relief for our already strained healthcare system.”  

This bombshell finding comes from a letter from Douglas J. Peterson, Attorney General, as well as James A Campbell, Solicitor General, and Mindy L. Lester, Assistant Attorney General to Dannette R. Smith, Chief Executive Officer, Nebraska Department of Health and Human Services.